Advisor Group’s Vanda Pharmaceuticals VNDA Stock Holding History

Advisor Group’s Portfolio VNDA Stock Details VNDA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	$34K	Sell	2,085 -846	-29%	-$12.8K	﹤0.01%	3667
2019 Q3	$39K	Sell	2,931 -781	-21%	-$10.9K	﹤0.01%	3562
2019 Q2	$52K	Hold	3,712	–	–	﹤0.01%	3334
2019 Q1	$68K	Buy	3,712 +796	+27%	+$18.1K	﹤0.01%	3164
2018 Q4	$77K	Buy	2,916 +1,161	+66%	+$27.3K	﹤0.01%	2864
2018 Q3	$40K	Hold	1,755	–	–	﹤0.01%	3445
2018 Q2	$33K	Hold	1,755	–	–	﹤0.01%	3405
2018 Q1	$30K	Hold	1,755	–	–	﹤0.01%	3431
2017 Q4	$27K	Hold	1,755	–	–	﹤0.01%	3518
2017 Q3	$31K	Hold	1,755	–	–	﹤0.01%	3289
2017 Q2	$29K	Hold	1,755	–	–	﹤0.01%	3241
2017 Q1	$25K	Buy	+1,755	New	+$25K	﹤0.01%	3232

Other funds holding VNDA

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Prudential Financial Newark, New Jersey $81.2B AUM 27.81% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Advisor Group's VNDA Position: Q4 2019 in Review

Advisor Group reduced its Vanda Pharmaceuticals (VNDA) stake by 29% in Q4 2019, selling an estimated $12.8K and leaving 2,085 shares worth $34K. The position accounts for ﹤0.01% of the portfolio, ranked #3667.

Advisor Group first reported a position in VNDA in Q1 2017 and has held it in 12 quarters since. The position peaked at $77K in Q4 2018. 179 funds tracked by Wall St. Rank hold VNDA as of Q4 2019.

Advisor Group held 2,085 shares of Vanda Pharmaceuticals worth $34K as of Q4 2019.
Advisor Group sold 846 Vanda Pharmaceuticals shares in Q4 2019, an estimated $12.8K.
Vanda Pharmaceuticals made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #3667 holding.
Advisor Group first reported a position in Vanda Pharmaceuticals in Q1 2017 and has held it in 12 quarters since.
Advisor Group's Vanda Pharmaceuticals position peaked at $77K in Q4 2018.
179 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.